The mission of the Journal of Orthomolecular Medicine is to advance knowledge and improve the practice of orthomolecular medicine by educating practitioners of orthomolecular medicine, inspiring scholars, students and future leaders with novel, relevant and high quality metabolic research, clinical studies and reports, and informative topic reviews and well-argued commentaries. The journal aims to engage the orthomolecular medicine community by providing a forum for debate and the promulgation of new ideas.
Since 1968, this quarterly Journal for health professionals has published the best of nutritional research and clinical trials. New articles describing the orthomolecular approach to health management and treatment of disease are accompanied by lively editorials, book reviews, letters and reports. The Journal of Orthomolecular Medicine has led the way in presenting, far in advance of other medical journals, new health concerns and treatments including: Candidiasis; Mercury Amalgam Toxicity; Niacin Therapy for Schizophrenia and Coronary Disease; Chronic Fatigue Syndrome; Vitamin C and Cancer; Allergies and Behavioral Disorders; Drug and Alcohol Abuse; Tissue and Mineral Analysis; and Orthomolecular Treatment for AIDS and Cardiovascular Disease.